Industries

Medical devices

Medical-device supply chains combine specialised suppliers, identification and traceability requirements, and validated production or sterilisation steps. Decisions on components and supply are taken by people, by your own MRP and planning rules, and by the agents of suppliers, sterilisation providers and procurement vendors. Aidecis gives them one authority model and one decision record, connected to the evidence and without bypassing validated release processes.

Current challenges

  • Specialised component shortages can threaten supply continuity.
  • Changes may affect validated production, sterilisation or product documentation.
  • Traceability evidence must stay connected across suppliers and internal hand-offs.

How Aidecis helps

  • Register the software that already decides, such as MRP runs, replenishment rules, and supplier or procurement agents, with an owner, limits and a mode.
  • Enforced control: your own integration checks Aidecis's single-use grant before a proposed change runs, and is held for the relevant evidence and quality review.
  • Observed control: when a supplier's or procurement vendor's agent changes an order in its own system, Aidecis reads the change afterwards, checks it against that agent's role and limits, and flags it within minutes if it went outside them. It does not prevent the change.
  • Route authority exceptions to named owners without bypassing validated release processes.
  • Automation stays low on the scale: agents and algorithms prepare and propose (autonomy level 1 to 2), and qualified people decide. Component changes, sterilisation exceptions and anything that touches validated processes or UDI data never move to bot mode.
  • How far a decision may climb also depends on your maturity in that decision family. For basic or digital organisations we propose reviewed assistance and bounded pilots, not bot mode. Agent-to-agent chains are opened one chain at a time, as a bounded pilot, never by default.

Benefits

  • Less avoidable delay in reviewing component changes.
  • Clearer accountability for supplier and sterilisation exceptions.
  • Component changes proposed by people or by software held to the same quality review.

We agree a baseline with your team, measure every benefit in the pilot and count each one once.

Operating context

MDR and UDI requirements for relevant EU medical devices; applicable quality and validation procedures.

Benefits

What could this mean for your network?

Explore potential benefits and your investment.

Calculate benefits and investment